CLDN18 and neoplasm: A recent study highlighted different rates of CLDN18 positivity in FNBs vs. surgical specimens [58]; this striking finding leads the consensus panel to its strong recommendation that at least 50 viable infiltrating tumor cells should be evaluated in order to obtain a reliable result.